CDKN2A and breast cancer: Since it mediates silencing p15INK4b by binding to SUZ12 [14], and p16INK4a locus through CBX7 (a PRC1 component) recruitment [12], which is frequently silenced in BC [23], we analyzed its expression in our patient dataset.